News / Health

Experimental Malaria Vaccine Falls Short

A mother holds her baby as she receives a new malaria vaccine at the Walter Reed Project Research Center in Kenya, October 30, 2009. A mother holds her baby as she receives a new malaria vaccine at the Walter Reed Project Research Center in Kenya, October 30, 2009.
x
A mother holds her baby as she receives a new malaria vaccine at the Walter Reed Project Research Center in Kenya, October 30, 2009.
A mother holds her baby as she receives a new malaria vaccine at the Walter Reed Project Research Center in Kenya, October 30, 2009.
VOA News
The world's first experimental malaria vaccine produced disappointing results in a large-scale test among African infants, raising questions about its potential for fighting the disease.

The vaccine, promoted as a new weapon in the malaria fight, reduced the risk of malaria by only 30 percent. The study involved more than 6,500 babies aged six to 12 weeks.

The results, released Friday, showed the vaccine providing less than half the protection it did in a previous smaller trial involving infants. The report said the "modest protection" the vaccine, which is also known as RTS,S or Mosquirix, has been provided in this latest trial was also lower than the 50 percent reported last year among older children.

Dr. Jennifer Cohn, a doctor with Doctors Without Borders, told the Associated Press that the vaccine’s effectiveness was “unacceptably low.”

Vaccinating babies is seen as a more cost effective way of battling the disease since it could be added to the regimen of other infant vaccinations.

Billionaire Microsoft founder and philanthropist Bill Gates, whose foundation is helping fund the vaccine, said the effectiveness rate came back lower than hoped.

But the top British drug manufacturer developing the vaccine, GlaxoSmithKline (GSK), will continue its efforts. Chief executive Andrew Witty said the drugmaker remains convinced the vaccine has a role to play in tackling malaria.

“We’ve been at this for 30 years, and we’re certainly not going to give up now, he said during a conference call with reporters.

The company, which has invested $300 million in the drug, does not expect to profit from the drug, which will be sold only in poor countries.

“The results look bad now, but they will probably be worse later,” said Adrian Hill of Oxford University to the Associated Press.

The results were released during a conference in South Africa Friday as part of a continuing study that will end in 2014.

The World Health Organization estimates that more than 650,000 people die from the mosquito-borne illness each year. The vast majority are children in sub-Saharan Africa.

You May Like

US Imposes Sanctions on Alleged Honduran Drug Gang

Treasury department alleges Los Valles group is responsible for smuggling tens of thousands of kilograms of cocaine into US each month More

At 91, Marvel Creator Stan Lee Continues to Expand his Universe

Company's chief emeritus hopes to interest new generation of children in superheroes of all shapes and sizes by publishing content across multiple media platforms More

Photogallery New Drug Protects Against Virus in Ebola Family

Study by researchers at University of Texas Medical Branch, Tekmira Pharmaceuticals is first looking at drug's effectiveness after onset of symptoms More

This forum has been closed.
Comment Sorting
Comments
     
by: Karel Eekels from: Middleburg, Virginia
December 02, 2012 6:31 PM
Plasmodium Falciparum is the parasite causing malignant malaria in humans. I strongly suggest for interested parties to google this.

MMS (Miracle Mineral Solution) consists of chlorine dioxide. Lemon and especially apple cider vinegar generates chlorine dioxide on a smaller scale (than the on the market available MMS
solution) it oxidizes the pathogens and kills or eliminates to a large extend the pathogens and has no side effects.

Jim Humble who came up with this formula treated thousands and thousands of malaria patients on the African and South American continent that were doomed with great success but was and continues to be shunned as a voodoo practitioner by the medical and pharmaceutical industry. Wonder why?? Is there not enough money to be made on this? I always have this on me when I work and have my boots on the ground in these regions.

Respectfully submitted.

Karel Eekels


by: Sawaki from: Japan
November 14, 2012 6:05 PM
Africa is important for our world economic growth, while we can not expect Europe and the United States.
So we need to invest for Africa and save the children's life from deadly diseases.


by: Anonymous
November 09, 2012 3:05 PM
It's worth the fight! Please keep of the valiant efforts of solving this evil virus.

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Five Patients Given Experimental Ebola Drug Said to Be Improvingi
X
Carol Pearson
August 19, 2014 11:43 PM
The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video Five Patients Given Experimental Ebola Drug Said to Be Improving

The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As the Ukrainian military reclaims control of eastern cities from pro-Russian separatists, residents are getting a chance to rebuild their lives. VOA's Gabe Joselow reports from the town of Kramatorsk in Donetsk province, where a sense of fear is still in the air, and distrust of the government in Kyiv still runs deep.
Video

Video China Targets Overseas Assets of Corrupt Officials

As China presses forward with its anti-graft effort, authorities are targeting corrupt officials who have sent family members and assets overseas. The efforts have stirred up a debate at home on exactly how many officials take that route and how likely it is they will be caught. Rebecca Valli has this report.
Video

Video Leading The Fight Against Islamic State, Kurds Question Iraqi Future

Western countries including the United States have begun arming the Kurdish Peshmerga forces in northern Iraq to aid their battle against extremist Sunni militants from the Islamic State. But there are concerns that a heavily-armed Kurdistan Regional Government, or KRG, might seek to declare independence and cause the break-up of the Iraqi state. As Henry Ridgwell reports from London, the KRG says it will only seek greater autonomy from Baghdad.
Video

Video In Rural Kenya, Pressure Builds Against Female Circumcision

In some Kenyan communities, female genital mutilation remains a rite of passage. But activists are pushing back, with education for girls and with threats of punishment those who perform the circumcision. Mohammed Yusuf looks at the practice in the rural eastern community of Tharaka-Nithi.
Video

Video For Obama, Racial Violence is Personal Issue

The racial violence in the St. Louis suburb of Ferguson is presenting U.S. President Barack Obama with an issue to which he has a deep personal connection. To many Americans, Obama's election as America's first black president marked a turning point in race relations in the United States, and Obama has made ending the violence a policy priority. On Monday he issued a new call for calm and understanding. Luis Ramirez reports from the White House.
Video

Video Clinton-Obama Relationship Could Impact 2016 Election

President Barack Obama and former Secretary of State Hillary Clinton have a long and complicated relationship. That relationship took another turn recently when Clinton criticized the president’s foreign policy. VOA National Correspondent Jim Malone reports there is renewed attention on the Clinton-Obama relationship as Hillary Clinton considers running for
Video

Video Iran Looks to Maintain Influence in Baghdad With New Shia PM

Washington and Tehran share the goal of stopping Syrian-based militants in Iraq. But experts say it's Iran, not the United States, that will most influence how the new government in Baghdad approaches internal reforms and the war in Syria. VOA State Department Correspondent Scott Stearns has the story.

AppleAndroid